The microenvironment of HPV-associated and HPV-negative oropharyngeal tumors

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11310%2F23%3A10465712" target="_blank" >RIV/00216208:11310/23:10465712 - isvavai.cz</a>

Výsledek na webu

<a href="https://www.ifhnos2023.com/selected-abstracts/" target="_blank" >https://www.ifhnos2023.com/selected-abstracts/</a>

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

The microenvironment of HPV-associated and HPV-negative oropharyngeal tumors

Popis výsledku v původním jazyce

Patients with HPV-associated oropharyngeal tumors have a survival advantage. They have better treatment response and less frequently develop recurrence. This recognition led to the inclusion of the indirect marker of an active viral infection -an expression of p16 protein -to the scoring system for oropharyngeal tumors and allowed for better risk stratification of patients. The substantially better prognosis of patients with HPV-associated oropharyngeal tumors stimulated the discussion about modification of the therapy with the aim to decrease the side effects of the treatment by lowering the dose of chemotherapy or radiation

Název v anglickém jazyce

The microenvironment of HPV-associated and HPV-negative oropharyngeal tumors

Popis výsledku anglicky

Patients with HPV-associated oropharyngeal tumors have a survival advantage. They have better treatment response and less frequently develop recurrence. This recognition led to the inclusion of the indirect marker of an active viral infection -an expression of p16 protein -to the scoring system for oropharyngeal tumors and allowed for better risk stratification of patients. The substantially better prognosis of patients with HPV-associated oropharyngeal tumors stimulated the discussion about modification of the therapy with the aim to decrease the side effects of the treatment by lowering the dose of chemotherapy or radiation

Druh

O - Ostatní výsledky

CEP obor

—

OECD FORD obor

30204 - Oncology

Projekt

<a href="/cs/project/LX22NPO5103" target="_blank" >LX22NPO5103: Národní institut virologie a bakteriologie</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2023

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů